首页 | 本学科首页   官方微博 | 高级检索  
     

酶抑制剂类抗糖尿病药物的分子水平筛选方法研究进展
引用本文:张海枝,刘鹏,李川,刘长鹰. 酶抑制剂类抗糖尿病药物的分子水平筛选方法研究进展[J]. 国外医药(植物药分册), 2014, 0(8): 947-952
作者姓名:张海枝  刘鹏  李川  刘长鹰
作者单位:天津药物研究院天津市新药设计与发现重点实验室,天津,300193
摘    要:酶抑制剂类抗糖尿病药物是目前药物研究的热点,而药物筛选技术是制约此类抗糖尿病新药研发速度的关键步骤。主要从分子水平总结近年来报道的与糖尿病相关的酶抑制剂类候选药物的筛选方法,包括传统方法和前沿方法,着重介绍极具潜力的毛细管电泳法、质谱法、生物传感法和微通道筛选方法等。

关 键 词:抗糖尿病药物  酶抑制剂  分子水平  药物筛选方法

Research progress on drug screening methods at the molecular level for enzyme inhibitors used as anti-diabetic drugs
ZHANG Hai-zhi , LIU Peng , LI Chuan , LIU Chang-ying. Research progress on drug screening methods at the molecular level for enzyme inhibitors used as anti-diabetic drugs[J]. , 2014, 0(8): 947-952
Authors:ZHANG Hai-zhi    LIU Peng    LI Chuan    LIU Chang-ying
Affiliation:( Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China)
Abstract:Various enzyme inhibitors have been demonstrated to be a hotspot in the research area of anti-diabetic drugs, whose development has been greatly limited by the efficiency of diverse drug screening methods. This paper concerns on different types of drug screening methods in the molecular level for enzyme inhibitors used in diabete treatment, including both traditional and advanced methods. Importantly, several screening methods with great potential have been emphasized here, such as capillary electrophoresis, mass spectrometry, biosensors, screening methods based on microchannel and so on.
Keywords:anti-diabetic drugs  enzyme inhibitors  molecular level  drug screening methods
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号